Unravel Biosciences

Medford, MA · Founded 2021 · Privately Held (backing)

Developer of an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases. Unravel Biosciences is based in Medford, MA and was founded in 2021. It was valued at $18 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $4.5 million across 2 recorded rounds; the latest was a $500,000 seed round in Feb 2023.

PMV mark · valuation
$18.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$4.5M
Last round
Seed Round
Feb 2023
What is Unravel Biosciences worth?
$18.0MPrivateMarketView mark · Oct 2026

Valued at $18.0M at its early-stage round, Sep 2025. Nothing has traded since.

Free account
More of Unravel Biosciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch Unravel Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Unravel Biosciences funding history

2 rounds
DateRoundRaisedPost-money
Feb 2023Seed Round$500K▮
Jul 2021Seed Round$500K▮
Unlock post-money valuations

Membership and data by Private Market View

Unravel Biosciences valuation

Unravel Biosciences was valued at $18 million at its early-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Unravel Biosciences raised?

Unravel Biosciences has raised $4.5 million in total; 2 of its rounds are on record. The largest on record was a $500,000 seed round in Feb 2023.

Unravel Biosciences has filed 2 Form Ds with the SEC since 2021, most recently in Mar 2023 ($500,000 sold to 4 investors).

How Unravel Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Unravel Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Unravel Biosciences

What is Unravel Biosciences worth?
Unravel Biosciences is valued at $18.0M as of Oct 2026. Valued at $18.0M at its early-stage round, Sep 2025. Nothing has traded since.
How much has Unravel Biosciences raised?
Unravel Biosciences has raised $4.5M in total funding across 2 recorded rounds.
When did Unravel Biosciences last raise?
Unravel Biosciences last raised in Feb 2023 (Seed Round), raising $500K.